 |
Previous Article | Next Article 
Volume 16, Number 19,
Issue of October 1, 1996
pp. 5986-5992
Copyright ©1996 Society for Neuroscience
2-Adrenergic Agonists Induce Basic Fibroblast
Growth Factor Expression in Photoreceptors In Vivo and
Ameliorate Light Damage
Received March 1, 1996; revised June 14, 1996; accepted July 15, 1996.
Rong Wen1, 2,
Tong Cheng3, 4,
Yiwen Li5,
Wei Cao3, 4, and
Roy H. Steinberg3, 4
Departments of 1 Ophthalmology and 2 Cell
and Developmental Biology, School of Medicine, University of
Pennsylvania, Philadelphia, Pennsylvania 19104, and Departments of
3 Physiology, 4 Ophthalmology, and
5 Neurology, University of California, San Francisco,
San Francisco, California 94143
We observed an induction of basic fibroblast growth factor (bFGF)
mRNA in the rat retina after systemic administration of the
2-adrenergic agonists xylazine and clonidine. A single
injection of xylazine or clonidine transiently increased bFGF mRNA.
Preinjection of yohimbine, an 2-adrenergic antagonist,
completely inhibited this increase. Higher dosage of yohimbine
inhibited the baseline expression of bFGF. Of particular interest is
the finding that the induced bFGF expression occurred almost
exclusively in the inner segment region of photoreceptors. No increase
in bFGF mRNA was found in the brain after either xylazine or clonidine
injection. Xylazine or clonidine given systemically before and during
constant light exposure also reduces photoreceptor degeneration in
albino rats. These results indicate that regulation of bFGF expression
in photoreceptors is unique in the CNS and suggest that endogenous bFGF
promotes photoreceptor survival.
Key words:
2-adrenergic receptors;
xylazine;
clonidine;
bFGF;
retina;
photoreceptors;
degeneration;
brain;
rat
This article has been cited by other articles:

|
 |

|
 |
 
M. Saylor, L. K. McLoon, A. R. Harrison, and M. S. Lee
Experimental and Clinical Evidence for Brimonidine as an Optic Nerve and Retinal Neuroprotective Agent: An Evidence-Based Review
Arch Ophthalmol,
April 1, 2009;
127(4):
402 - 406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-J. Dong, Y. Guo, L. Wheeler, and W. A. Hare
{alpha}2 Adrenergic Receptor-Mediated Modulation of Cytosolic Ca++ Signals at the Inner Plexiform Layer of the Rat Retina
Invest. Ophthalmol. Vis. Sci.,
March 1, 2007;
48(3):
1410 - 1415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mayor-Torroglosa, P. De la Villa, M. E. Rodriguez, M. P. L. Lopez-Herrera, M. Aviles-Trigueros, A. Garcia-Aviles, J. Miralles de Imperial, M. P. Villegas-Perez, and M. Vidal-Sanz
Ischemia Results 3 Months Later in Altered ERG, Degeneration of Inner Layers, and Deafferented Tectum: Neuroprotection with Brimonidine
Invest. Ophthalmol. Vis. Sci.,
October 1, 2005;
46(10):
3825 - 3835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F B Kalapesi, M T Coroneo, and M A Hill
Human ganglion cells express the alpha-2 adrenergic receptor: relevance to neuroprotection
Br J Ophthalmol,
June 1, 2005;
89(6):
758 - 763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tomita, Y. Kotake, and R. E. Anderson
Mechanism of Protection from Light-Induced Retinal Degeneration by the Synthetic Antioxidant Phenyl-N-tert-Butylnitrone
Invest. Ophthalmol. Vis. Sci.,
February 1, 2005;
46(2):
427 - 434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Ranchon, M. M. LaVail, Y. Kotake, and R. E. Anderson
Free Radical Trap Phenyl-N-tert-Butylnitrone Protects against Light Damage But Does Not Rescue P23H and S334ter Rhodopsin Transgenic Rats from Inherited Retinal Degeneration
J. Neurosci.,
July 9, 2003;
23(14):
6050 - 6057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-C. Fintz, I. Audo, D. Hicks, S. Mohand-Said, T. Leveillard, and J. Sahel
Partial Characterization of Retina-Derived Cone Neuroprotection in Two Culture Models of Photoreceptor Degeneration
Invest. Ophthalmol. Vis. Sci.,
February 1, 2003;
44(2):
818 - 825.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Baptiste, A. T. E. Hartwick, C. A. B. Jollimore, W. H. Baldridge, B. C. Chauhan, F. Tremblay, and M. E. M. Kelly
Comparison of the Neuroprotective Effects of Adrenoceptor Drugs in Retinal Cell Culture and Intact Retina
Invest. Ophthalmol. Vis. Sci.,
August 1, 2002;
43(8):
2666 - 2676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Gao, X. Qiao, L. B. Cantor, and D. WuDunn
Up-regulation of Brain-Derived Neurotrophic Factor Expression by Brimonidine in Rat Retinal Ganglion Cells
Arch Ophthalmol,
June 1, 2002;
120(6):
797 - 803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Traverso, R. A. Bush, P. A. Sieving, and D. Deretic
Retinal cAMP Levels during the Progression of Retinal Degeneration in Rhodopsin P23H and S334ter Transgenic Rats
Invest. Ophthalmol. Vis. Sci.,
May 1, 2002;
43(5):
1655 - 1661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. WoldeMussie, G. Ruiz, M. Wijono, and L. A. Wheeler
Neuroprotection of Retinal Ganglion Cells by Brimonidine in Rats with Laser-Induced Chronic Ocular Hypertension
Invest. Ophthalmol. Vis. Sci.,
November 1, 2001;
42(12):
2849 - 2855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Lafuente, M. P. Villegas-Perez, P. Sobrado-Calvo, A. Garcia-Aviles, J. Miralles de Imperial, and M. Vidal-Sanz
Neuroprotective Effects of {alpha}2-Selective Adrenergic Agonists against Ischemia-Induced Retinal Ganglion Cell Death
Invest. Ophthalmol. Vis. Sci.,
August 1, 2001;
42(9):
2074 - 2084.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Ranchon, S. Chen, K. Alvarez, and R. E. Anderson
Systemic Administration of Phenyl-N-tert-Butylnitrone Protects the Retina from Light Damage
Invest. Ophthalmol. Vis. Sci.,
May 1, 2001;
42(6):
1375 - 1379.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. E. Donello, E. U. Padillo, M. L. Webster, L. A. Wheeler, and D. W. Gil
{alpha}2-Adrenoceptor Agonists Inhibit Vitreal Glutamate and Aspartate Accumulation and Preserve Retinal Function after Transient Ischemia
J. Pharmacol. Exp. Ther.,
January 1, 2001;
296(1):
216 - 223.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. LevkovitchVerbin, C. HarrisCerruti, Y. Groner, L. A. Wheeler, M. Schwartz, and E. Yoles
RGC Death in Mice after Optic Nerve Crush Injury: Oxidative Stress and Neuroprotection
Invest. Ophthalmol. Vis. Sci.,
December 1, 2000;
41(13):
4169 - 4174.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. M. Peterson, Q. Wang, R. Tzekova, and S. J. Wiegand
Ciliary Neurotrophic Factor and Stress Stimuli Activate the Jak-STAT Pathway in Retinal Neurons and Glia
J. Neurosci.,
June 1, 2000;
20(11):
4081 - 4090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Bylund and D. M. Chacko
Characterization of {alpha}2 Adrenergic Receptor Subtypes in Human Ocular Tissue Homogenates
Invest. Ophthalmol. Vis. Sci.,
September 1, 1999;
40(10):
2299 - 2306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Fontaine, N. Kinkl, J. Sahel, H. Dreyfus, and D. Hicks
Survival of Purified Rat Photoreceptors In Vitro Is Stimulated Directly by Fibroblast Growth Factor-2
J. Neurosci.,
December 1, 1998;
18(23):
9662 - 9672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ozaki, N. Okamoto, S. Ortega, M. Chang, K. Ozaki, S. Sadda, M. A. Vinores, N. Derevjanik, D. J. Zack, C. Basilico, et al.
Basic Fibroblast Growth Factor Is Neither Necessary nor Sufficient for the Development of Retinal Neovascularization
Am. J. Pathol.,
September 1, 1998;
153(3):
757 - 765.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Liu, M. Peng, A. M. Laties, and R. Wen
Preconditioning with Bright Light Evokes a Protective Response against Light Damage in the Rat Retina
J. Neurosci.,
February 15, 1998;
18(4):
1337 - 1344.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|